科研动态PubMed 摘要

通过使用自定义的按需(PRN)适应症优化阿片类药物重复治疗警报。

PubMed 白名单日捞 · 2026-11-10

完整摘要 · 中文译文

目的:阿片类镇痛药常用于住院患者疼痛控制。重复治疗警示用于预防不良反应并维持对联合委员会(The Joint Commission)的合规性;然而,警示量高和临床相关性低会导致警示疲劳和脱敏。利用医嘱集、重复治疗允许规则和方案可以优化重复治疗警示,但仍存在进一步改进的空间。 方法:这项回顾性研究评估了在一个大型社区健康系统中通过优化速释(IR)阿片类重复治疗警示来减少警示量的流程。研究纳入归因于成人住院患者至少2条PRN(必要时)阿片类医嘱的警示。在第一阶段,健康系统实施临床决策支持逻辑,对不同PRN适应症的警示进行静默处理。在第二阶段,药学部门在电子阿片类医嘱中创建了新的离散PRN适应症复选框,在第三阶段修订了医嘱集以支持新的适应症。在第四阶段,从警示中移除了无关药物。主要结局是每1,000条PRN阿片类医嘱的重复治疗警示数。药学部门在各自独立的1周期间评估了警示量和医嘱量。 结果:干预前,每1,000条PRN阿片类医嘱有1,382条重复治疗警示。干预后,每1,000条PRN阿片类医嘱触发378条重复治疗警示,较基线下降72.6%。在两组中,大多数IR阿片类重复治疗警示发生在外科 的临床环境,并且70%的情况下被覆盖。 结论:通过临床决策支持工具、离散的PRN适应症框和医嘱套餐审查来优化阿片类药物重复治疗警报的努力,减少了与PRN阿片类药物医嘱相关的警报负担。

完整摘要 · 英文原文

PURPOSE: Opioid analgesics are commonly prescribed for inpatient pain control. Duplicate therapy alerts exist to prevent adverse effects and maintain compliance with The Joint Commission; however, high alert volume and low clinical relevance contribute to alert fatigue and desensitization. Leveraging order sets, duplicate therapy allowances, and protocols can optimize duplicate therapy alerts, but further opportunity for improvement exists. METHODS: This retrospective study evaluated a process to reduce alert volume by optimizing immediate-release (IR) opioid duplicate therapy alerts in a large community health system. The study included alerts attributed to at least 2 PRN (as-needed) opioid orders for adult inpatients. In phase I, the health system implemented clinical decision support logic to silence alerts for different PRN indications. In phase II, the pharmacy department created new discrete PRN indication checkboxes within electronic opioid orders, and in phase III order sets were revised to support the new indications. In phase IV, extraneous medications were removed from the alert. The primary outcome was the number of duplicate therapy alerts per 1,000 PRN opioid orders. The pharmacy department assessed alert and order volumes in separate 1-week periods. RESULTS: Before intervention, there were 1,382 duplicate therapy alerts per 1,000 PRN opioid orders. After intervention, 378 duplicate therapy alerts fired per 1,000 PRN opioid orders, representing a 72.6% decrease from baseline. In both groups, the majority of IR opioid duplicate therapy alerts occurred in surgical settings and were overridden 70% of the time. CONCLUSION: Efforts to optimize opioid duplicate therapy alerts through clinical decision support tools, discrete PRN indication boxes, and order set review resulted in decreased alert burden associated with PRN opioid orders.

English
Opioid duplicate therapy alert optimization through use of custom PRN indications.
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界